The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
Open accessAbstract
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide [1]. The long-term hepatic impact of HCV infection is highly variable, from minimal changes to chronic hepatitis, extensive fibrosis, and cirrhosis with or without hepatocellular carcinoma (HCC). The number of chronically infected persons worldwide may exceed 200 million, but most of them have no knowledge of their infection or of the ensuing hepatic condition. Clinical care for patients with HCV-related liver disease has advanced considerably during the last two decades, as a result of growing knowledge about the mechanisms of the disease, remarkable developments in diagnostic procedures, and advances in therapeutic and preventative approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,836
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,826
Diagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
Simmonds, P., Bukh, J., Combet, C., Deléage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspé, G., Kuiken, C., Maertens, G., et al. (2005) · Hepatology · doi:10.1002/hep.20819 · Cited by 1,516
Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis
Friedrich–Rust, M., Ong, M., Martens, S., Sarrazin, C., Bojunga, J., Zeuzem, S., & Herrmann, E. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.034 · Cited by 1,490
Non-invasive evaluation of liver fibrosis using transient elastography
Castera, L., Forns, X., & Alberti, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.008 · Cited by 1,430
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,368
Hepatocellular carcinoma: a global view
Yang, J. D., & Roberts, L. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.100 · Cited by 1,286
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
McHutchison, J. G., Lawitz, E. J., Shiffman, M. L., Muir, A. J., Galler, G. W., McCone, J., Nyberg, L. M., Lee, W. M., Ghalib, R. H., Schiff, E. R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808010 · Cited by 1,190
Rauch, A., Kutalik, Z., Descombes, P., Cai, T., Di Iulio, J., Mueller, T., Bochud, M., Battegay, M., Bernasconi, E., Borovicka, J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.056 · Cited by 1,137
Orens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., Egan, T., Keshavjee, S., Knoop, C., Kotloff, R., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.011 · Cited by 1,073
The association between hepatitis C infection and survival after orthotopic liver transplantation
Forman, L. M., Lewis, J. D., Berlin, J. A., Feldman, H. I., & Lucey, M. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32418 · Cited by 1,031
McHutchison, J. G., Manns, M., Patel, K., Poynard, T., Lindsay, K. L., Trepo, C., Dienstag, J., Lee, W. M., Mak, C., Garaud, J., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35950 · Cited by 969
Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3
Mangia, A., Santoro, R., Minerva, N., Ricci, G. L., Carretta, V., Persico, M., Vinelli, F., Scotto, G., Bacca, D., Annese, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042608 · Cited by 840
Davis, G. L., Wong, J. B., McHutchison, J. G., Manns, M. P., Harvey, J., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50364 · Cited by 819
Vento, S., Garofano, T., Renzini, C., Cainelli, F., Casali, F., Ghironzi, G., Ferraro, T., & Concia, E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380503 · Cited by 795
Romero-Gómez, M., Del Mar Viloria, M., Andrade, R. J., Salmerón, J., Diago, M., Fernández-Rodríguez, C. M., Corpas, R., Cruz, M., Grande, L., Vázquez, L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.049 · Cited by 732
Treating viral hepatitis C: efficacy, side effects, and complications
Manns, M. P., Wedemeyer, H., & Cornberg, M. (2006) · Gut · doi:10.1136/gut.2005.076646 · Cited by 659
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1002/hep.1840360730 · Cited by 556
Sources of variability in histological scoring of chronic viral hepatitis†
Rousselet, M., Michalak, S., Dupré, F., Croué, A., Bedossa, P., Saint‐André, J., & Calès, P. (2005) · Hepatology · doi:10.1002/hep.20535 · Cited by 540
Prieto, M., Berenguer, M., Rayón, J. M., Córdoba, J., Argüello, L., Carrasco, D., García-Herola, A., Olaso, V., De Juan, M., Gobernado, M., et al. (1999) · Hepatology · doi:10.1002/hep.510290122 · Cited by 537
Qurishi, N., Kreuzberg, C., Lüchters, G., Effenberger, W., Kupfer, B., Sauerbruch, T., Rockstroh, J. K., & Spengler, U. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14844-1 · Cited by 525
Hepatitis C virus kinetics during and immediately after liver transplantation
Garcia-Retortillo, M., Forns, X., Feliu, A., Moitinho, E., Costa, J., Navasa, M., Rimola, A., & Rodes, J. (2002) · Hepatology · doi:10.1053/jhep.2002.31773 · Cited by 503
Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3
Shiffman, M. L., Suter, F., Bacon, B. R., Nelson, D., Harley, H., Solá, R., Shafran, S. D., Barange, K., Lin, A., Soman, A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066403 · Cited by 493
The changing epidemiology of hepatitis C virus infection in Europe
Esteban, J. I., Sauleda, S., & Quer, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.033 · Cited by 481
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Di Bisceglie, A. M., Shiffman, M. L., Everson, G. T., Lindsay, K. L., Everhart, J. E., Wright, E. C., Lee, W. M., Lok, A. S., Bonkovsky, H. L., Morgan, T. R., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707615 · Cited by 465
ZEUZEM, S. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.007 · Cited by 448
Eltrombopag for Thrombocytopenia in Patients with Cirrhosis Associated with Hepatitis C
McHutchison, J. G., Dusheiko, G., Shiffman, M. L., Rodriguez-Torres, M., Sigal, S., Bourliere, M., Berg, T., Gordon, S. C., Campbell, F. M., Theodore, D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073255 · Cited by 448
Degos, F., Perez, P., Roche, B., Mahmoudi, A., Asselineau, J., Voitot, H., & Bedossa, P. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.035 · Cited by 435
George, S. L., Bacon, B. R., Brunt, E. M., Mihindukulasuriya, K. L., Hoffmann, J., & Di Bisceglie, A. M. (2009) · Hepatology · doi:10.1002/hep.22694 · Cited by 399
Shaheen, A. A. M., & Myers, R. P. (2007) · Hepatology · doi:10.1002/hep.21835 · Cited by 397
Alberti, A., Clumeck, N., Collins, S., Gerlich, W., Lundgren, J., Palù, G., Reiss, P., Thiebaut, R., Weiland, O., Yazdanpanah, Y., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.003 · Cited by 382
Bressler, B. L., Guindi, M., Tomlinson, G., & Heathcote, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50350 · Cited by 358
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
Parkes, J., Roderick, P., Harris, S., Day, C., Mutimer, D., Collier, J., Lombard, M., Alexander, G., Ramage, J., Dusheiko, G., et al. (2010) · Gut · doi:10.1136/gut.2009.203166 · Cited by 351
Carrión, J. A., Navasa, M., García-Retortillo, M., García‐Pagán, J. C., Crespo, G., Bruguera, M., Bosch, J., & Forns, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.041 · Cited by 347
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
Neumann, U. P., Berg, T., Bahra, M., Seehofer, D., Langrehr, J. M., Neuhaus, R., Radke, C., & Neuhaus, P. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.029 · Cited by 339
Treatment predictors of a sustained virologic response in hepatitis B and C
Kau, A., Vermehren, J., & Sarrazin, C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.013 · Cited by 324
Schaefer, M., Schmidt, F., Folwaczny, C., Lorenz, R., Martin, G., Schindlbeck, N., Heldwein, W., Soyka, M., Grunze, H., Koenig, A., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50031 · Cited by 324
Tillmann, H. L., Thompson, A. J., Patel, K., Wiese, M., Tenckhoff, H., Nischalke, H. D., Lokhnygina, Y., Kullig, U., Göbel, U., Capka, E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.005 · Cited by 322
Viral hepatitis and HIV coinfection
Sulkowski, M. S. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.009 · Cited by 316
Hepatitis C genotype 4: What we know and what we don't yet know†
Kamal, S. M., & Nasser, I. A. (2008) · Hepatology · doi:10.1002/hep.22127 · Cited by 301
Blasco, A., Forns, X., Carrión, J. A., García-Pagán, J. C., Gilabert, R., Rimola, A., Miquel, R., Bruguera, M., García-Valdecasas, J.-C., Bosch, J., et al. (2006) · Hepatology · doi:10.1002/hep.21090 · Cited by 293
Yu, M., Dai, C., Huang, J., Hou, N., Lee, L.-P., Hsieh, M., Chiu, C.-F., Lin, Z.-Y., Chen, S., Hsieh, M., et al. (2006) · Gut · doi:10.1136/gut.2006.102558 · Cited by 286
Berenguer, M., Palau, A., Aguilera, V., Rayón, J.-M., Juan, F. S., & Prieto, M. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02126.x · Cited by 283
Pearlman, B. L., Ehleben, C., & Saifee, S. (2007) · Hepatology · doi:10.1002/hep.21919 · Cited by 269
van de Laar, T. J., Matthews, G. V., Prins, M., & Danta, M. (2010) · AIDS · doi:10.1097/qad.0b013e32833c11a5 · Cited by 252
Wiegand, J., Buggisch, P., Boecher, W., Zeuzem, S., Gelbmann, C. M., Berg, T., Kauffmann, W., Kallinowski, B., Cornberg, M., Jaeckel, E., et al. (2006) · Hepatology · doi:10.1002/hep.21043 · Cited by 250
Expert opinion on the treatment of patients with chronic hepatitis C
Zeuzem, S., Berg, T., Moeller, B., Hinrichsen, H., Mauss, S., Wedemeyer, H., Sarrazin, C., Hueppe, D., Zehnter, E., & Manns, M. P. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01012.x · Cited by 242
Wright, M., Grieve, R., Roberts, J., Main, J., & Thomas, H. (2006) · Health Technology Assessment · doi:10.3310/hta10210 · Cited by 230
Castéra, L., Sebastiani, G., Le Bail, B., de Lédinghen, V., Couzigou, P., & Alberti, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.008 · Cited by 214
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis
Thompson Coon, J., Rogers, G., Hewson, P., Wright, D., Anderson, R., Cramp, M., Jackson, S., Ryder, S., Price, A., & Stein, K. (2007) · Health Technology Assessment · doi:10.3310/hta11340 · Cited by 195
Lok, A. S., Everhart, J. E., Wright, E. C., Di Bisceglie, A. M., Kim, H., Sterling, R. K., Everson, G. T., Lindsay, K. L., Lee, W. M., Bonkovsky, H. L., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.050 · Cited by 192
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
Antaki, N., Craxi, A., Kamal, S., Moucari, R., Van der Merwe, S., Haffar, S., Gadano, A., Zein, N., Lai, C. L., Pawlotsky, J.-M., et al. (2010) · Liver International · doi:10.1111/j.1478-3231.2009.02188.x · Cited by 186
Carrión, J. A., Martínez-Bauer, E., Crespo, G., Ramírez, S., Pérez-del-Pulgar, S., García-Valdecasas, J. C., Navasa, M., & Forns, X. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.11.015 · Cited by 185
Romero-Gómez, M., Fernández-Rodríguez, C. M., Andrade, R. J., Diago, M., Alonso, S., Planas, R., Solá, R., Pons, J. A., Salmerón, J., Barcena, R., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.022 · Cited by 185
Parkes, J., Guha, I. N., Roderick, P., Harris, S., Cross, R., Manos, M. M., Irving, W., Zaitoun, A., Wheatley, M., Ryder, S., et al. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01263.x · Cited by 180
SAFE biopsy: A validated method for large‐scale staging of liver fibrosis in chronic hepatitis C†
Sebastiani, G., Halfon, P., Castera, L., Pol, S., Thomas, D. L., Mangia, A., Marco, V. D., Pirisi, M., Voiculescu, M., Guido, M., et al. (2009) · Hepatology · doi:10.1002/hep.22859 · Cited by 180
Management of chronic viral hepatitis before and after renal transplantation
Gane, E., & Pilmore, H. (2002) · Transplantation · doi:10.1097/00007890-200208270-00001 · Cited by 175
Jensen, D. M., Marcellin, P., Freilich, B., Andreone, P., Di Bisceglie, A., Brandão-Mello, C. E., Reddy, K. R., Craxi, A., Martin, A. O., Teuber, G., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-8-200904210-00007 · Cited by 175
Castera, L. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01087.x · Cited by 172
Asian Pacific Association for the Study of the Liver (APASL) Hepatitis C Working Party (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04883.x · Cited by 169
Sarrazin, C., Berg, T., Ross, R., Schirmacher, P., Wedemeyer, H., Neumann, U., Schmidt, H., Spengler, U., Wirth, S., Kessler, H., et al. (2010) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0028-1110008 · Cited by 168
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
Torresi, J., Johnson, D., & Wedemeyer, H. H. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.040 · Cited by 165
Alcohol Use and Treatment of Hepatitis C Virus: Results of a National Multicenter Study
Anand, B. S., Currie, S., Dieperink, E., Bini, E. J., Shen, H., Ho, S. B., & Wright, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.023 · Cited by 162
Mauss, S., Berger, F., Goelz, J., Jacob, B., & Schmutz, G. (2004) · Hepatology · doi:10.1002/hep.20279 · Cited by 161
Hepatitis C virus-induced hepatocarcinogenesis
Bartosch, B., Thimme, R., Blum, H. E., & Zoulim, F. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.008 · Cited by 157
Safdar, K., & Schiff, E. R. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-832942 · Cited by 147
Schaefer, M., Hinzpeter, A., Mohmand, A., Janssen, G., Pich, M. G. L., Schwaiger, M., Sarkar, R., Friebe, A., Heinz, A., Kluschke, M., et al. (2007) · Hepatology · doi:10.1002/hep.21791 · Cited by 140
Hospital admission is a relevant source of hepatitis C virus acquisition in Spain
Martínez‐Bauer, E., Forns, X., Armelles, M., Planas, R., Sola, R. L., Vergara, M., Fábregas, S., Vega, R., Salmerón, J., Moisés Diago, M., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.031 · Cited by 136
Vermehren, J., Kau, A., Gärtner, B. C., Göbel, R., Zeuzem, S., & Sarrazin, C. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00755-08 · Cited by 116
Prevention and treatment of hepatitis C in injection drug users
Edlin, B. R. (2002) · Hepatology · doi:10.1002/hep.1840360727 · Cited by 111
Grieve, R., Roberts, J., Wright, M., Sweeting, M. J., Angelis, D. D., Rosenberg, W. M., Bassendine, M. F., Main, J., & Thomas, H. C. (2005) · Gut · doi:10.1136/gut.2005.064774 · Cited by 104
Potthoff, A., Wedemeyer, H. H., Boecher, W. O., Berg, T., Zeuzem, S., Arnold, J. C., Spengler, U., Grüngreiff, K., Kaeser, T., Schuchmann, M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.028 · Cited by 99
Extrahepatic Manifestations of Hepatitis C Virus Infection
Zignego, A. L., & Craxı̀, A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.03.012 · Cited by 90
Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes
Chevaliez, S., & Pawlotsky, J. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2008.11.004 · Cited by 89
Acute hepatitis C: diagnosis and management
Mondelli, M. U., Cerino, A., & Cividini, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.017 · Cited by 76
Biomarkers of Liver Injury for Hepatitis Clinical Trials: A Meta-Analysis of Longitudinal Studies
Poynard, T., Ngo, Y., Munteanu, M., Thabut, D., Massard, J., Moussalli, J., Varaud, A., Benhamou, Y., & Ratziu, V. (2010) · Antiviral Therapy · doi:10.3851/imp1570 · Cited by 65
(2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.08.001 · Cited by 61
Manns, M. P., Zeuzem, S., Sood, A., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.024 · Cited by 57
Schaefer, M., & Mauss, S. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801020177 · Cited by 53
Impact of viral eradication on mortality related to hepatitis C: A modeling approach in France
Deuffic‐Burban, S., Deltenre, P., Louvet, A., Canva, V., Dharancy, S., Hollebecque, A., Boitard, J., Henrion, J., Yazdanpanah, Y., & Mathurin, P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.04.012 · Cited by 52
Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon
Wiegand, J., Deterding, K., Cornberg, M., & Wedemeyer, H. H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn346 · Cited by 51
Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C
Sroczynski, G., Esteban, E., Conrads‐Frank, A., Schwarzer, R., Mühlberger, N., Wright, D. R., Zeuzem, S., & Siebert, U. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01147.x · Cited by 37
Bédossa, P. (2008) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(08)73989-7 · Cited by 35
Cited by
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
EASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
EASL Recommendations on Treatment of Hepatitis C 2015
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.025 · Cited by 1,156
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
(2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,096
Metadata
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 55
- Issue
- 2
- Pages
- 245-264
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4211077792
- Cited by
- 1,088
- References
- 93
- FWCI
- 120.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.